• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ARCHITECT HAVAB-G REAGENT KIT; HEPATITIS A TEST (ANTIBODY AND IGM ANTIBODY)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ARCHITECT HAVAB-G REAGENT KIT; HEPATITIS A TEST (ANTIBODY AND IGM ANTIBODY) Back to Search Results
Catalog Number 06C29-27
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/02/2021
Event Type  malfunction  
Event Description
The customer observed false reactive architect havab-igg results for one patient.The following data was provided (>/= to 1.00 s/co is reactive): 15dec2021 sid (b)(6) initial havab igg result was (b)(6) s/co (reactive), repeated (b)(6) s/co (nonreactive) (lot 31400be00) no impact to patient management was reported.
 
Manufacturer Narrative
Patient identifier = sid (b)(6).An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Manufacturer Narrative
Data and information provided by the customer were reviewed and support the complaint issue without indication for any additional issue.The ticket search by lot indicates that the reagent lots perform as expected for this product.Return testing was not performed as returns were not available.Trending review did not identify any trends for the complaint issue.Device history record review was performed on lot number 31400be00, which did not show any potential non-conformances, deviations, or non-conformances.The overall performance of architect havab igg reagents was reviewed using worldwide field data.Standard deviation to cutoff for the negative population and median values (for the negative population) for the complaint lot(s) are within the established limits and comparable to the historical reagent lot performance.Labeling review concludes that the issue is adequately addressed.Based on all reviewed data, we conclude that there is no general issue with the architect havab igg reagent lots identified in this complaint.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT HAVAB-G REAGENT KIT
Type of Device
HEPATITIS A TEST (ANTIBODY AND IGM ANTIBODY)
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford N39 E-932
433331157
MDR Report Key13370732
MDR Text Key285254891
Report Number3002809144-2022-00026
Device Sequence Number1
Product Code LOL
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/13/2022
Device Catalogue Number06C29-27
Device Lot Number31400BE00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/17/2022
Initial Date FDA Received01/27/2022
Supplement Dates Manufacturer Received02/16/2022
Supplement Dates FDA Received03/08/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/08/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC I2SR REFURB-SEKAT, 03M74-97, ISR03119; ARC I2SR REFURB-SEKAT, 03M74-97, ISR03119
-
-